Abeona Therapeutics Inc (ABEO) — Cash Flow-to-Debt Ratio
Abeona Therapeutics Inc (ABEO) has a Cash Flow-to-Debt Ratio of -0.30x as of December 2025, meaning its operating cash flow of $-17.95 Million could theoretically repay 0% of its total liabilities ($60.35 Million) in one year. See Abeona Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Abeona Therapeutics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Abeona Therapeutics Inc across 31 annual periods. Also explore Abeona Therapeutics Inc (ABEO) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Abeona Therapeutics Inc (1995–2025)
Year-by-year debt coverage analysis for Abeona Therapeutics Inc. For market capitalisation and broader financial context, see ABEO company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.26x | $-76.33 Million | $60.35 Million | ▼ -46.5% |
| 2024 | -0.86x | $-56.02 Million | $64.90 Million | ▼ -14.7% |
| 2023 | -0.75x | $-37.01 Million | $49.18 Million | ▲ +35.2% |
| 2022 | -1.16x | $-43.48 Million | $37.45 Million | ▲ +34.2% |
| 2021 | -1.76x | $-65.67 Million | $37.22 Million | ▼ -145.1% |
| 2020 | -0.72x | $-35.02 Million | $48.65 Million | ▲ +48.5% |
| 2019 | -1.40x | $-62.82 Million | $44.95 Million | ▼ -44.2% |
| 2018 | -0.97x | $-39.11 Million | $40.35 Million | ▲ +63.4% |
| 2017 | -2.65x | $-22.93 Million | $8.67 Million | ▼ -143.2% |
| 2016 | -1.09x | $-13.01 Million | $11.96 Million | ▼ -28.8% |
| 2015 | -0.85x | $-10.42 Million | $12.33 Million | ▼ -517.2% |
| 2014 | -0.14x | $-1.61 Million | $11.77 Million | ▼ -210847.2% |
| 2013 | 0.00x | $1.00K | $15.39 Million | ▲ +100.0% |
| 2012 | -0.21x | $-3.96 Million | $18.81 Million | ▲ +40.9% |
| 2011 | -0.36x | $-7.61 Million | $21.39 Million | ▼ -53.3% |
| 2010 | -0.23x | $-6.86 Million | $29.57 Million | ▼ -194.9% |
| 2009 | -0.08x | $-2.25 Million | $28.57 Million | ▲ +81.6% |
| 2008 | -0.43x | $-6.56 Million | $15.36 Million | ▼ -174.7% |
| 2007 | 0.57x | $4.84 Million | $8.47 Million | ▲ +576.5% |
| 2006 | -0.12x | $-1.96 Million | $16.31 Million | ▲ +81.2% |
| 2005 | -0.64x | $-7.30 Million | $11.45 Million | ▼ -24.7% |
| 2004 | -0.51x | $-9.08 Million | $17.75 Million | ▼ -41.7% |
| 2003 | -0.36x | $-6.36 Million | $17.64 Million | ▲ +20.3% |
| 2002 | -0.45x | $-8.60 Million | $19.00 Million | ▼ -40.8% |
| 2001 | -0.32x | $-5.27 Million | $16.41 Million | ▼ -15.1% |
| 2000 | -0.28x | $-4.33 Million | $15.52 Million | ▲ +91.4% |
| 1999 | -3.25x | $-3.25 Million | $1.00 Million | ▲ +39.2% |
| 1998 | -5.33x | $-3.20 Million | $600.00K | ▼ -24.7% |
| 1997 | -4.28x | $-3.63 Million | $848.00K | ▼ -39.2% |
| 1996 | -3.07x | $-2.67 Million | $868.00K | ▼ -306.9% |
| 1995 | 1.49x | $658.00K | $443.00K | — |